2012-2022 Report on Global Zika Virus Market Competition, Status and Forecast, Market Size by Players, Regions, Type, Application

The Global Zika Virus Market 2016 Industry Trend and Forecast 2021 is a professional and in-depth study on the current state of the Zika Virus industry.

Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Zika Virus market analysis is provided for the international market including development history, competitive landscape analysis, and major regions? development status.

Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (North America, EU, China and Japan), and other regions can be added.

Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What?s more, the Zika Virus industry development trends and marketing channels are analyzed.

Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.

In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table of Contents

1 Industry Overview of Zika Virus 1
Definition and Specifications of Zika Virus 1
1.1.1 Definition and Specifications of Zika Virus 1
1.1.2 Signs and Symptoms 2
1.1.3 Complications of Zika Virus Disease 3
1.1.4 Diagnosis Zika Virus 3
1.1.5 Treatment Zika Virus 4
1.1.6 WHO Response to Zika Virus 4
2 Transmission of Zika Virus 5
2.1 Mosquito Bites 6
2.1.1 Life Stages of Aedes Aegypti and Aedes Albopictus Mosquitoes 8
2.1.2 Aedes Aegypti 11
2.1.3 Aedes Albopictus 12
2.2 Pregnancy 14
2.3 Sexual Transmission 14
2.4 Blood Transfusion 15
2.4.1 Zika Virus Blood Screening 15
2.4.2 Blood Collection Centers and Health Departments 15
3 Zika Virus, Microcephaly and Guillain-Barre Syndrome 16
3.1 Zika Virus, Microcephaly and Guillain-Barre Syndrome 16
3.2 Microcephaly 17
3.2.1 Signs and Symptoms 17
3.2.2 Causes of Microcephaly 17
3.2.3 Diagnosis and Treatment 18
3.3 Guillain-Barre Syndrome 18
3.3.1 Signs and Symptoms 20
3.3.2 Causes of Guillain-Barre 21
3.3.3 Diagnosis 21
3.4 Dengue and Climate 21
4 Development of Zika Virus 24
4.1 History of Zika Virus 24
4.1.1 1947--1964 24
4.2.2 1960s-1980s 26
4.2.3 2007--2014 26
4.2.4 Situation in 2015 27
4.2.5 Situation in 2016 28
4.2.6 Zika: the origin and spread of a mosquito-borne virus conclusion 29
4.2 Timeline of Zika Virus 30
4.3 Distribution of Zika Virus 31
4.3.1 Distribution of Zika Virus 31
4.3.2 Predicted Habitats of Mosquito Transmits Zika Virus 33
5 Zika Virus Situation by Countries 34
5.1 Current Zika Transmission Situation by Countries 34
5.2 Current Zika Transmission Situation by Regions 36
5.3 Countries and Territories Reporting Mosquito-borne Zika Virus Transmission 36
5.4 Response Funding of Zika Virus 38
6 Operational Response Analysis of Zika Virus 41
6.1 Surveillance of Zika Virus 41
6.1.1 Enhanced Surveillance and Monitoring 41
6.1.2 Laboratories and diagnostics 41
6.1.3 Rapid response 41
6.2 Community Engagement & Risk Communication of Zika Virus 43
6.2.1 Public Health Risk Communication 43
6.2.2 Health Care Personnel 43
6.3 Care for Those Affected of Zika Virus 45
6.3.1 Clinical Guidance and Protocols 45
6.3.2 Preparation of Healthcare Facilities 45
6.3.3 Pre-pregnancy, Maternal and Post-natal Care 45
7 Main Countries Response Analysis of Zika Virus 47
7.1 Brazil Response Analysis of Zika Virus 47
7.1.1 Brazil Zika Virus 47
7.1.2 Brazil Response of Zika Virus 48
7.2 USA Response Analysis of Zika Virus 48
7.1.1 USA Zika Virus 48
7.2.2 USA Response of Zika Virus 49
7.3 Other Countries of Response Analysis of Zika Virus 50
8 Research Situation of Major Companies Analysis of Zika Virus 51
8.1 Bharat Biotech 51
8.1.1 Company Profile 51
8.1.2 Research Status 52
8.2 Inovio Pharmaceuticals and GeneOne Life Sciences 52
8.2.1 Inovio Pharmaceuticals Company Profile 52
8.2.2 GeneOne Life Sciences Company Profile 53
8.2.3 Research Status 54
8.3 Intrexon 55
8.3.1 Company Profile 55
8.3.2 Research Status 56
8.4 Cerus 57
8.4.1 Company Profile 57
8.4.2 Research Status 58
8.5 Sanofi 59
8.5.1 Company Profile 59
8.5.2 Research Status of Sanofi 60
8.6 NewLink Genetics 61
8.6.1 Company Profile 61
8.6.2 Research Status 62
8.7 Immunovaccine 62
8.7.1 Company Profile 62
8.7.2 Research Status 63
8.8 GlaxoSmithKline 65
8.8.1 Company Profile 65
8.8.2 Research Status 66
9 Major Manufacturers Analysis of Zika Virus 67
9.1 ATCC 67
9.1.1 Company Profile 67
9.1.2 Zika Virus (ATCC? VR-84?) 68
9.2 ZeptoMetrix 69
9.1.3 Zika Virus (ATCC? VR-1838?) 69
9.2.1 Company Profile 70
9.2.2 Product Picture and Specifications 70
10 Other Similar Infectious Diseases and Forecast of Zika Virus 71
10.1 Overview of Yellow Fever 71
10.1.1 Definitions and Features of Yellow Fever 71
10.1.2 Distribution of Yellow Fever 72
10.1.3 Transmission of Yellow Fever 72
10.1.4 Yellow Fever Vaccine 73
10.2 Forecast of Zika Virus 74
11 Conclusion of the Global Zika Virus Market 2016 Industry Trend and Forecast 2021 75

List of Tables and Figures

Figure Picture of Zika Virus a Cross-section 1
Figure Picture Parts of Zika Virus 2
Table Signs and Symptoms of Zika Virus 2
Table Diagnosis of Zika Virus 3
Table Treatment Zika Virus 4
Table Treatment Zika Virus 4
Table Transmission of Zika Virus 5
Figure Spreads of Zika Virus 5
Figure United States Estimated Range of Aedes Albopictus and Aedes Aegypti in 2016 6
Figure Europe Range of Aedes Albopictus and Aedes Aegypti in 2016 6
Table Compared of Aedes Aegypti and Aedes Albopictus 7
Figure Mosquito Life Cycle 8
Figure Mosquito Life Cycle in Laboratory 9
Table Specifications of Aedes Aegypti 9
Figure Picture of Aedes Aegypti 11
Table Specifications of Aedes Aegypti 11
Table Entomology of Aedes Aegypti 11
Figure Picture of Aedes Albopictus 12
Table Specifications of Aedes Albopictus 13
Table Distribution of Aedes Albopictus 13
Table Entomology of Aedes Albopictus 13
Table Summary of Zika Virus, Microcephaly and Guillain-Barre Syndrome 16
Table Key Facts of Microcephaly 17
Table Key Facts of Guillain-Barre 18
Figure Spectrum of Disorders in the Guillain-Barre Syndrome and Associated Antiganglioside Antibodies 19
Figure Possible Immunopathogenesis of the Guillain-Barre Syndrome 20
Figure Picture of Dengue 22
Figure Picture of Sentinel Rhesus Monkey 25
Table Situation in 2015 of Aedes Aegypti 27
Table Situation in 2016 of Aedes Aegypti 28
Figure 1947-2014 Timeline of Zika Virus 30
Figure 2015 Timeline of Zika Virus 30
Figure 2016 Timeline of Zika Virus 31
Figure Countries, Territories and Areas Distribution of Zika Virus until May 2016 31
Figure Countries and Territories with Active Zika Virus Transmission until May 2016 32
Figure Predicted Habitats of Mosquito Transmits the Zika Virus 33
Figure Predicted Habitats of a Second Mosquito Transmits the Zika Virus 33
Table Current Zika Transmission Situation by Countries 34
Figure Current Zika Transmission Wroldwide 35
Figure Zika Virus Cumulative Number of Countries, Territories and Areas by Regions in Years, 2007-2014, and Monthly from 1 January 2015 to 8 June 2016 36
Table Countries and Territories Reporting Mosquito-borne Zika Virus Transmission 36
Table Countries and Territories Reporting Countries Non Vector-borne Zika Virus Transmission 38
Figure Zika Response Founding Gap for WHO/PAHO 39
Figure Contributions for Zika Emergency Response 40
Figure Key Activities by Authoritative Organizations 42
Figure Key Activities by Authoritative Organizations 43
Table Key Activities by Authoritative Organizations 45
Figure Distribution of Brazil Zika Virus 47
Figure Distribution of USA Zika Virus 49
Table USA Response of Zika Virus 49
Table Bharat Biotech Information List 51
Table Inovio Pharmaceuticals Information List 52
Table GeneOne Life Sciences Information List 53
Figure Research Status of Inovio Pharmaceuticals 54
Table Intrexon Information List 55
Figure Research Status of Intrexon 56
Table Cerus Information List 57
Figure Research Status of Cerus 58
Table Sanofi Information List 59
Figure Research Status of Sanofi 60
Table NewLink Genetics Information List 61
Table Immunovaccine Information List 62
Figure Research Status of Immunovaccine 63
Table GlaxoSmithKline Information List 65
Figure Research Status of GlaxoSmithKline 66
Table ATCC Information List 67
Table Specifications of Zika Virus (ATCC? VR-84?) 68
Table Specifications of (ATCC? VR-1838?) 69
Table ZeptoMetrix Information List 70
Table Product Specifications 70
Figure Distribution of Yellow Fever 72
Table Yellow Fever Vaccine Price in Main Regions in 2015 73
Figure Yellow Fever Vaccine Manufacturers with WHO Prequalified YFV 73
Table UNICEF YFV 2015 Supply and 2016-2017 Awards 74

Choose License Type